Longitudinal Assessment of Lipid and Hepatic Clinical Parameters in Workers Involved With the Demolition of Perfluoroalkyl Manufacturing Facilities
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 54 (8) , 974-983
Abstract
Objective: To examine in a longitudinal occupational assessment whether changes in serum concentrations of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) are associated with changes in non–high-density lipoprotein (HDL) cholesterol. Methods: Baseline and end-of-project PFOA, PFOS, lipid, and hepatic clinical chemistries were measured in 204 workers involved with the demolition of former perfluoroalkyl manufacturing facilities. Analyses were restricted to the 179 workers who did not take lipid-lowering medications. Two thirds had baseline PFOA and PFOS levels similar to the general population. Results: The change in non-HDL cholesterol was not associated with the changes in PFOA or PFOS. An increase in HDL was associated with an increase in PFOA, although the magnitude was small. This increase in HDL resulted in a decrease in the total cholesterol/HDL ratio. Conclusion: Adverse associations were not observed between changes in PFOA, PFOS, non-HDL cholesterol, HDL, and hepatic clinical chemistries.Keywords
This publication has 39 references indexed in Scilit:
- Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytesToxicology, 2011
- Perfluorooctanoic Acid, Perfluorooctanesulfonate, and Serum Lipids in Children and AdolescentsArchives of Pediatrics & Adolescent Medicine, 2010
- Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)Environmental Health Perspectives, 2010
- Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination SurveyEnvironmental Health Perspectives, 2010
- Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West VirginiaEnvironmental Health Perspectives, 2010
- Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. PopulationEnvironmental Health Perspectives, 2010
- Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production WorkersEnvironmental Health Perspectives, 2007
- Longitudinal Study of Serum Lipids and Liver Enzymes in Workers With Occupational Exposure to Ammonium PerfluorooctanoateJournal of Occupational and Environmental Medicine, 2007
- Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health ParametersJournal of Occupational and Environmental Medicine, 2006
- Pharmacodynamics and Pharmacokinetic-Pharmacodynamic Relationships of Atorvastatin, an HMG-CoA Reductase InhibitorThe Journal of Clinical Pharmacology, 2000